Session » Muscle Biology, Myositis and Myopathies Poster

Date: Sunday, November 8, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 294

A Decline in Pulmonary Function over One Year Predicts Outcome in Myositis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 304

Abnormal Pulmonary Function Tests, Interstitial Lung Disease, and Lung Function Decline in Patients with Classic and Clinically Amyopathic Dermatomyositis

9:00AM-11:00AM: Abstract Number: 283

Altered Serum Fatty Acid Profiles in Patients with Polymyositis or Dermatomyositis Compared to Healthy Individuals and in Relation to Immunosuppressive Treatment

9:00AM-11:00AM: Abstract Number: 282

Angiogenesis in Fasciitis Associated with Dermatomyositis

9:00AM-11:00AM: Abstract Number: 290

Cancer and Necrotizing Immune Mopathy: High Incidence in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive and Seronegative Patients but Not in Anti-Single Recognition Particle Positive Patients

9:00AM-11:00AM: Abstract Number: 300

Causes of Creatine Kinase Levels Greater Than 1,000 IU/L in Patients Referred to Rheumatology

9:00AM-11:00AM: Abstract Number: 291

Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 296

Different Patterns of Involvement of Thigh Muscles in Dermatomyositis and Polymyositis Using Fat-Suppressed Magnetic Resonance Sequences

9:00AM-11:00AM: Abstract Number: 301

Economic Burden of Sporadic Inclusion Body Myositis in the United States of America: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 289

Evaluation of Usefulness of Krebs Von Den Lungen-6 As a Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including in the Short Time Course after Treatment

9:00AM-11:00AM: Abstract Number: 281

Health Related Quality of Life Is Reduced in Adult Patients with Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 297

How Useful Is Magnetic Resonance Imaging (MRI) in Monitoring Patients with Myositis?

9:00AM-11:00AM: Abstract Number: 287

Interleukin-35 in Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 298

Investigating the Pathogenic Role of ER Stress Pathway Activation in the Idiopathic Inflammatory Myopathies (IIM): Skeletal Muscle Cells As a Source of Cytokines (Myokines)

9:00AM-11:00AM: Abstract Number: 306

Investigating the Pathogenic Role of ER Stress Pathways in the Idiopathic Inflammatory Myopathies (IIM): Interrogating the Role of Micro-RNA 133a As an Important Regulator of ER Stress Activation

9:00AM-11:00AM: Abstract Number: 293

Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 303

Mining RNA-Seq of Peripheral Blood Mononuclear Cells from JDM Alone Compared with JDM Plus Psoriasis for Biomarkers of Disease Activity

9:00AM-11:00AM: Abstract Number: 288

Myositis Associated Interstitial Lung Disease: Clinical Predictors of Failure to Conventional Treatment and Their Response to Tacrolimus

9:00AM-11:00AM: Abstract Number: 308

Nailfold Capillaroscopy in Patients with Early Onset-Dermatomyositis

9:00AM-11:00AM: Abstract Number: 292

Neoepitope Biomarkers As Biomarkers of Polymyositis and Dermatomyositis and Functional Status

9:00AM-11:00AM: Abstract Number: 309

Plasma Levels of Heat Shock Protein 90 Are Increased in Idiopathic Inflammatory Myopathies and Correlate with Disease Activity, Skeletal Muscle, Heart and Lung Involvement

9:00AM-11:00AM: Abstract Number: 295

Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index Among Dermatologists, Rheumatologists, and Neurologists

9:00AM-11:00AM: Abstract Number: 302

Resource Utilization in a US Sample of Patients with Sporadic Inclusion Body Myositis

9:00AM-11:00AM: Abstract Number: 307

Screening for Pulmonary Hypertension in the Anti-Synthetase Syndrome; Utility of Four Different Screening Approaches

9:00AM-11:00AM: Abstract Number: 299

Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody

9:00AM-11:00AM: Abstract Number: 305

The “Sleeve Sign”� in Dermatomyositis

9:00AM-11:00AM: Abstract Number: 280

The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 285

Tobacco Smoking in Different Racial Groups Is Differentially Associated with the Development of Myositis Autoantibodies and Interstitial Lung Disease in the Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 284

Validation of the Sporadic Inclusion Body Myositis Physical Functioning Assessment

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].